Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use.

Kwun J, Matignon M, Manook M, Guendouz S, Audard V, Kheav D, Poullot E, Gautreau C, Ezekian B, Bodez D, Damy T, Faivre L, Menouch D, Yoon J, Park J, Belhadj K, Chen D, Bilewski AM, Yi JS, Collins B, Stegall M, Farris AB, Knechtle S, Grimbert P.

J Am Soc Nephrol. 2019 Jul;30(7):1206-1219. doi: 10.1681/ASN.2018121254. Epub 2019 Jun 21.

PMID:
31227636
2.

Accelerated ISAV replication detection by cell culture methods combined with time-monitoring RT-qPCR.

Arseneau JR, Gautreau C, Boston L, Goguen ML, Laflamme M.

J Fish Dis. 2019 Feb;42(2):257-267. doi: 10.1111/jfd.12925. Epub 2018 Nov 29.

PMID:
30488967
3.

Favorable Outcome of an Exclusively Posttransplant Prophylactic Strategy After Heart Transplantation in Recipients With High Immunological Risk.

Coutance G, d'Orio V, Belin L, Bréchot N, Saheb S, Lebreton G, Bouglé A, Rouvier P, Gautreau C, Ouldammar S, Chamillard X, Huot M, Amour J, Combes A, Leprince P, Varnous S.

Transplantation. 2019 Jul;103(7):1439-1449. doi: 10.1097/TP.0000000000002503.

PMID:
30376551
4.

Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome.

Brugière O, Roux A, Le Pavec J, Sroussi D, Parquin F, Pradère P, Dupin C, Bunel V, Mourin G, Jebrak G, Dauriat G, Castier Y, Mordant P, Lortat-Jacob B, Jean-Baptiste S, Mal H, Suberbielle C, Gautreau C, Caillat-Zucman S, Cazes A, Thabut G, Taupin JL.

Eur Respir J. 2018 Aug 23;52(2). pii: 1701898. doi: 10.1183/13993003.01898-2017. Print 2018 Aug.

PMID:
29976654
5.

Antibody-mediated rejection induced cardiogenic shock: Too late for conventional therapy.

Coutance G, Van Aelst L, Hékimian G, Vidal C, Rouvier P, Saheb S, Gautreau C, Leprince P, Varnous S.

Clin Transplant. 2018 May;32(5):e13253. doi: 10.1111/ctr.13253. Epub 2018 Apr 30.

PMID:
29626851
6.

Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation.

Roux A, Bendib Le Lan I, Holifanjaniaina S, Thomas KA, Picard C, Grenet D, De Miranda S, Douvry B, Beaumont-Azuar L, Sage E, Devaquet J, Cuquemelle E, Le Guen M, Suberbielle C, Gautreau C, Stern M, Rossetti M, Hamid AM, Parquin F.

Front Med (Lausanne). 2017 Oct 11;4:155. doi: 10.3389/fmed.2017.00155. eCollection 2017.

7.

Analysis of Transfusion-Related Acute Lung Injury and Possible Transfusion-Related Acute Lung Injury Reported to the French Hemovigilance Network From 2007 to 2013.

Andreu G, Boudjedir K, Muller JY, Pouchol E, Ozier Y, Fevre G, Gautreau C, Quaranta JF, Drouet C, Rieux C, Mertes PM, Clavier B, Carlier M, Sandid I.

Transfus Med Rev. 2018 Jan;32(1):16-27. doi: 10.1016/j.tmrv.2017.07.001. Epub 2017 Jul 15. Review.

PMID:
28864336
8.

Are perfectionistic concerns an antecedent of or a consequence of binge eating, or both? A short-term four-wave longitudinal study of undergraduate women.

Smith MM, Sherry SB, Gautreau CM, Stewart SH, Saklofske DH, Mushquash AR.

Eat Behav. 2017 Aug;26:23-26. doi: 10.1016/j.eatbeh.2017.01.001. Epub 2017 Jan 10.

PMID:
28135619
9.

Enhancement motives moderate the relationship between high-arousal positive moods and drinking quantity: Evidence from a 22-day experience sampling study.

Gautreau C, Sherry S, Battista S, Goldstein A, Stewart S.

Drug Alcohol Rev. 2015 Nov;34(6):595-602. doi: 10.1111/dar.12235. Epub 2015 Mar 4.

PMID:
25735401
10.

Does catastrophizing of bodily sensations maintain health-related anxiety? A 14-day daily diary study with longitudinal follow-up.

Gautreau CM, Sherry SB, Sherry DL, Birnie KA, Mackinnon SP, Stewart SH.

Behav Cogn Psychother. 2015 Jul;43(4):502-12. doi: 10.1017/S1352465814000150. Epub 2014 May 1.

PMID:
24785012
11.

Lung transplantation in patients with pretransplantation donor-specific antibodies detected by Luminex assay.

Brugière O, Suberbielle C, Thabut G, Lhuillier E, Dauriat G, Metivier AC, Gautreau C, Charron D, Mal H, Parquin F, Stern M.

Transplantation. 2013 Mar 15;95(5):761-5. doi: 10.1097/TP.0b013e31827afb0f.

PMID:
23296148
12.

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation.

Lefaucheur C, Loupy A, Hill GS, Andrade J, Nochy D, Antoine C, Gautreau C, Charron D, Glotz D, Suberbielle-Boissel C.

J Am Soc Nephrol. 2010 Aug;21(8):1398-406. doi: 10.1681/ASN.2009101065. Epub 2010 Jul 15.

13.

Immune responses elicited in tertiary lymphoid tissues display distinctive features.

Thaunat O, Graff-Dubois S, Brouard S, Gautreau C, Varthaman A, Fabien N, Field AC, Louedec L, Dai J, Joly E, Morelon E, Soulillou JP, Michel JB, Nicoletti A.

PLoS One. 2010 Jun 30;5(6):e11398. doi: 10.1371/journal.pone.0011398.

14.

Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis.

Thaunat O, Patey N, Caligiuri G, Gautreau C, Mamani-Matsuda M, Mekki Y, Dieu-Nosjean MC, Eberl G, Ecochard R, Michel JB, Graff-Dubois S, Nicoletti A.

J Immunol. 2010 Jul 1;185(1):717-28. doi: 10.4049/jimmunol.0903589. Epub 2010 Jun 4.

15.

Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection.

Lefaucheur C, Nochy D, Andrade J, Verine J, Gautreau C, Charron D, Hill GS, Glotz D, Suberbielle-Boissel C.

Am J Transplant. 2009 May;9(5):1099-107. doi: 10.1111/j.1600-6143.2009.02591.x.

16.

Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation.

Lefaucheur C, Suberbielle-Boissel C, Hill GS, Nochy D, Andrade J, Antoine C, Gautreau C, Charron D, Glotz D.

Contrib Nephrol. 2009;162:1-12. doi: 10.1159/000170788. Epub 2008 Oct 31.

PMID:
19001809
17.

[Lymphoid neogenesis and lymphangiogenesis: two newcomers in the pathophysiology of chronic rejection].

Attuil-Audenis V, Duthey A, Patey N, Gautreau C, McGregor B, Morelon E, Michel JB, Nicoletti A, Thaunat O.

Nephrol Ther. 2009 Apr;5(2):91-6. doi: 10.1016/j.nephro.2008.05.004. Epub 2008 Aug 3. Review. French.

PMID:
18678539
18.

14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis.

Ozawa M, Terasaki PI, Castro R, Alberu J, Morales-Buenrostro L, Alvarez I, Toledo R, Alvez H, Monteiro M, Teixeira J, Campbell P, Ciszek M, Charron D, Gautreau C, Christiansen F, Langan L, Conca R, Grosse-Wilde H, Heinemann F, Kamoun M, Kobayashi T, Kupatawintu P, LeFor W, Mehra N, Panigrahi A, Norman D, Piazza A, Poli F, Roy R, Schonemann C, Lachmann N, Sireci G, Tanabe K, Ishida H, Van den Berg-Loonen E, Zeevi A.

Clin Transpl. 2007:255-60.

PMID:
18642456
19.

B cell survival in intragraft tertiary lymphoid organs after rituximab therapy.

Thaunat O, Patey N, Gautreau C, Lechaton S, Fremeaux-Bacchi V, Dieu-Nosjean MC, Cassuto-Viguier E, Legendre C, Delahousse M, Lang P, Michel JB, Nicoletti A.

Transplantation. 2008 Jun 15;85(11):1648-53. doi: 10.1097/TP.0b013e3181735723.

PMID:
18551073
20.

Donor-specific antibody detection for diagnosis of antibody-mediated rejection in kidney transplantation.

Gautreau C, Suberbielle C, Andrade J, Charron D.

Clin Transpl. 2006:502. No abstract available.

PMID:
18365411
21.

Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation.

Lefaucheur C, Suberbielle-Boissel C, Hill GS, Nochy D, Andrade J, Antoine C, Gautreau C, Charron D, Glotz D.

Am J Transplant. 2008 Feb;8(2):324-31. Epub 2007 Dec 19.

22.

14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project.

Ozawa M, Terasaki PI, Lee JH, Castro R, Alberu J, Alonso C, Alvarez I, Toledo R, Alvez H, Monterio M, Teixeira J, Campbell P, Ciszek M, Charron D, Gautreau C, Christiansen F, Conca R, Gomez B, Monteon F, Grosse-Wilde H, Heinemann F, Humar I, Kamoun M, Kimball P, Kobayashi T, Kupatawintu P, Leech S, LeFor W, Mehra N, Panigrahi A, Naumova E, Norman D, Piazza A, Poli F, Colombo B, Roy R, Schonemann C, Sireci G, Tanabe K, Ishida H, Van den Berg-Loonen E, Zeevi A.

Tissue Antigens. 2007 Apr;69 Suppl 1:174-9.

PMID:
17445195
23.

The role of HLA genes in familial spondyloarthropathy: a comprehensive study of 70 multiplex families.

Said-Nahal R, Miceli-Richard C, Gautreau C, Tamouza R, Borot N, Porcher R, Charron D, Dougados M, Breban M.

Ann Rheum Dis. 2002 Mar;61(3):201-6.

24.

Fab fragments from intravenous immunoglobulin prevent hyperacute rejection in the guinea pig-to-rat combination without reducing hemolytic complement activity in rat serum.

Urbani L, Cardoso J, Soubrane O, Houssin D, Gautreau C.

Transplant Proc. 2000 Dec;32(8):2707-9. No abstract available.

PMID:
11134770
25.

Prevalence of GBV C/HGV RNA and GBV C/HGV antibodies in French volunteer blood donors: results of a collaborative study.

Mercier B, Barclais A, Botte C, Cantalube J, Coste J, Defer C, Gautreau C, Giannoli C, Halfon P, Lepot I, Loiseau P, Martial J, Montcharmont P, Merel P, Ouzan D, Ravera N, Follana J, Césaire R, Janot C, Lemaire J, De Micco P, Vezon G, Férec C.

Vox Sang. 1999;76(3):166-9.

PMID:
10341332
26.

[Autologous transfusion and hemoglobin SC disease].

Lecam B, Woimant G, Gautreau C, Cherruau B, Conseiller C.

Ann Fr Anesth Reanim. 1999 Feb;18(2):233-6. French.

PMID:
10207597
27.

Predominant role of the Fab fragment in delaying hyperacute rejection in guinea pig-to-rat xenotransplantation.

Urbani L, Fabre M, Cardoso J, Lambin P, Devillier P, Soubrane O, Houssin D, Gautreau C.

Transplantation. 1998 Aug 15;66(3):395-7.

PMID:
9721810
28.

Intravenous immunoglobulin delays xenogeneic hyperacute rejection in a model of pig liver perfused with human blood.

Gautreau C, Grosse H, Fabre M, Soubrane O, Woimant G, Lobontiu A, Kojima T, Cherruau B, Devillier P, Houssin D, Cardoso J.

Transplant Proc. 1996 Apr;28(2):764. No abstract available.

PMID:
8623390
29.

Human anti-B alloantibodies recognize xenoantigens on pig red blood cells and endothelial cells.

Gautreau C, Woimant G, Grosse H, Cardoso J, Soubrane O, Houssin D.

Transplant Proc. 1996 Apr;28(2):563. No abstract available.

PMID:
8623273
30.

Use of intravenous immunoglobulin to delay xenogeneic hyperacute rejection. An in vivo and in vitro evaluation.

Gautreau C, Kojima T, Woimant G, Cardoso J, Devillier P, Houssin D.

Transplantation. 1995 Nov 15;60(9):903-7.

PMID:
7491691
31.

Human natural cytotoxic antibodies recognize cross-reactive antigens on pig endothelial cells and pig red blood cells.

Gautreau C, Cardoso J, Zhao Z, Chereau C, Woimant G, Houssin D, Weill B.

Transplant Proc. 1994 Jun;26(3):1397. No abstract available.

PMID:
8029956
32.

Lobular hemorrhage: an early parameter of rejection in isolated pig livers perfused with heparinized human blood.

Cardoso J, Gautreau C, Wroblewski T, Cherruau B, Neris J, Mestiri H, Crougneau S, Weill B, Houssin D.

Transplant Proc. 1994 Jun;26(3):1308-9. No abstract available.

PMID:
8029917
33.

Prevention of hyperacute xenograft rejection by intravenous immunoglobulin in the pig-to-human combination.

Gautreau C, Cardoso J, Woimant G, Zhao Z, Chereau C, Cherruau B, Vandeginste N, Devillier P, Houssin D.

Transplant Proc. 1994 Jun;26(3):1281. No abstract available.

PMID:
8029908
34.

Augmentation of portal blood flow improves function of human cirrhotic liver.

Cardoso JE, Gautreau C, Jeyaraj PR, Patrzalek D, Cherruau B, Vaubourdolle M, Legendre C, Wroblewski T, Houssin D.

Hepatology. 1994 Feb;19(2):375-80.

PMID:
8294094
35.

Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. In vitro analysis of complement activation.

Zhao Z, Termignon JL, Cardoso J, Chéreau C, Gautreau C, Calmus Y, Houssin D, Weill B.

Transplantation. 1994 Jan;57(2):245-9.

PMID:
8310516
36.

[Immuno-hematologic aspects of xenotransplantation].

Gautreau C, Houssin D.

Transfus Clin Biol. 1994;1(2):109-14. Review. French.

PMID:
8019644
37.
38.

Progression to AIDS in French haemophiliacs: association with HLA-B35.

Sahmoud T, Laurian Y, Gazengel C, Sultan Y, Gautreau C, Costagliola D.

AIDS. 1993 Apr;7(4):497-500.

PMID:
8507416
39.

Relationship between human natural anti-A, anti-B alloantibodies and anti-pig xenoantibodies.

Gautreau C, Cardoso J, Jeyaraj P, Houssin D, Weill B.

Transplant Proc. 1993 Feb;25(1 Pt 1):389-91. No abstract available.

PMID:
8438348
40.

Complement component C4 deficiencies and gene alterations in patients with systemic lupus erythematosus.

Fan Q, Uring-Lambert B, Weill B, Gautreau C, Menkes CJ, Delpech M.

Eur J Immunogenet. 1993 Feb;20(1):11-21.

PMID:
8095158
41.

[Preparation of maternal platelets collected by separator for use in fetal transfusion in a case of alloimmunization by anti-PLA1].

Woimant G, Gautreau C, Bardin JM, Brossard Y, Poissonnier MH, Pinon F.

Rev Fr Transfus Hemobiol. 1989 Jun;32(3):227-34. French.

PMID:
2765036
42.

[Safety of hepatitis B vaccine with regard to the transmission of HIV].

Gautreau C, Bardin JM, N'Guyen M, Pouliquen A, Kheang S, Pinon F.

Presse Med. 1987 Mar 21;16(10):491-2. French. No abstract available.

PMID:
2951678
43.

Hepatitis B vaccination and idiopathic haemochromatosis.

Saddi RS, Ebelin P, Pouliquen A, Gautreau C, Durand J, Jammet P, Courouce AM, Brechot C, Franco D, Thibult N.

Lancet. 1985 Nov 9;2(8463):1061-2. No abstract available.

PMID:
2865532
44.

Comparison of two methods of high-molecular-weight DNA isolation from human leucocytes.

Gautreau C, Rahuel C, Cartron JP, Lucotte G.

Anal Biochem. 1983 Oct 15;134(2):320-4.

PMID:
6196989
45.

[Polymorphism of DNA in human populations using the method of hybridization after transfer].

Lucotte G, Rahuel C, Gautreau C, Dandieu S, Cartron JP, Salmon C.

Rev Fr Transfus Immunohematol. 1982 Jun;25(3):279-96. Review. French. No abstract available.

PMID:
6287556
46.

[Electrophoretic distances between the three gibbon sub-genera (author's transl)].

Lucotte G, Gautreau C, Smith DG.

Ann Genet. 1982;25(1):11-3. French.

PMID:
6979293
47.

[Electrophoretic polymorphism in different subspecies of Cercopithecus aethiops].

Lucotte G, Gautreau C, Galat G, Galat-Luong A.

Folia Primatol (Basel). 1982;38(3-4):183-95. French.

PMID:
6957364

Supplemental Content

Loading ...
Support Center